Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 148 No. 0506 (2018)

Aortic valve replacement using autologous pericardium: single centre experience with the Ozaki technique

  • Oliver Reuthebuch
  • Luca Koechlin
  • Ulrich Schurr
  • Martin Grapow
  • Jens Fassl
  • Friedrich S. Eckstein
DOI
https://doi.org/10.4414/smw.2018.14591
Cite this as:
Swiss Med Wkly. 2018;148:w14591
Published
09.02.2018

Summary

OBJECTIVE

To assess the clinical implementation and report preliminary results of a novel technique called the Ozaki procedure for stentless aortic valve replacement through reconstruction of the valve leaflets from autologous pericardium.

METHOD

Between September 2015 and May 2017 30 patients (20 males, mean ± standard deviation age 66.83 ± 10.55 years) suffering from aortic stenosis (AS, n = 7), aortic regurgitation (AR, n = 12), or a combination of both (AS/AR, n = 11) were assigned for an Ozaki procedure. The glutaraldehyde-treated autologous pericardium was intraoperatively customised and tailored according to individual sinus measurements and appropriate Ozaki templates (CE marked).

RESULTS

Mean and peak preoperative transvalvular pressure gradients in patients with AS were 46.34 ± 14.71 and 78.00 ± 22.54 mm Hg, respectively and effective orifice area was 0.93 ± 0.26 cm2. Ejection fraction was preserved at 57.37 ± 10.33%. Twenty-four valves were tricuspid and 6 bicuspid; 13 patients had concomitant cardiac surgery (coronary artery bypass graft, mitral valve repair, replacement of ascending aorta).

​

Mean ± SD cross-clamp time for replacement only was 85.18 ± 18.10 minutes and perfusion time 104.76 ± 38.52 minutes. Cusp sizes were 27.76 ± 3.52 mm for the left coronary cusp (CC), 28.20 ± 3.51 mm for the right CC and 29.20 ± 3.34 mm for non-CC. Mean and peak postoperative gradients decreased to 8 ± 3.55 and 14.8 ± 6.21 mm Hg, respectively. Mean length of stay on the intensive care unit was 2.19 ± 2.34 days and in-hospital stay was 8.81 ± 2.04 days after isolated Ozaki procedures. No pacemaker had to be implanted after an isolated Ozaki procedure. Thirty-day mortality was 3.33% (n = 1). After 3 months, no patient presented with aortic stenosis, and regurgitation of the substituted valves was graded nil/trace in 85.71%, mild in 10.71%, and moderate in 3.57% of the patients. Ejection fraction remained unchanged at 58.89 ± 11.29%. No reoperation was required within the first 3 months.

CONCLUSION

This aortic valve replacement technique has become available only recently. In our experience, it can be mastered after a relatively short training period, and has become part of our routine clinical toolbox. The use of autologous pericardium in combination with excellent haemodynamics may have the potential to overcome the structural disadvantages of biological aortic valves, to be beneficial in infective endocarditis, and to represent an alternative for patients with small annuli.

References

  1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11. doi:.https://doi.org/10.1016/S0140-6736(06)69208-8
  2. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231–43. doi:.https://doi.org/10.1016/S0195-668X(03)00201-X
  3. Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111(7):920–5. doi:.https://doi.org/10.1161/01.CIR.0000155623.48408.C5
  4. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al.; ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42(4):S1–44. doi:.https://doi.org/10.1093/ejcts/ezs455
  5. Ozaki S, Kawase I, Yamashita H, Uchida S, Nozawa Y, Matsuyama T, et al. Aortic valve reconstruction using self-developed aortic valve plasty system in aortic valve disease. Interact Cardiovasc Thorac Surg. 2011;12(4):550–3. Published online January 27, 2011. doi:.https://doi.org/10.1510/icvts.2010.253682
  6. Ozaki S, Kawase I, Yamashita H, Uchida S, Takatoh M, Hagiwara S, et al. Aortic Valve Reconstruction Using Autologous Pericardium for Aortic Stenosis. Circ J. 2015;79(7):1504–10. doi:.https://doi.org/10.1253/circj.CJ-14-1092
  7. Narang S, Satsangi DK, Banerjee A, Geelani MA. Stentless valves versus stented bioprostheses at the aortic position: midterm results. J Thorac Cardiovasc Surg. 2008;136(4):943–7. doi:.https://doi.org/10.1016/j.jtcvs.2008.06.016
  8. Shultz BN, Timek T, Davis AT, Heiser J, Murphy E, Willekes C, et al. A propensity matched analysis of outcomes and long term survival in stented versus stentless valves. J Cardiothorac Surg. 2017;12(1):45. doi:.https://doi.org/10.1186/s13019-017-0608-2
  9. Repossini A, Fischlein T, Santarpino G, Schäfer C, Claus B, Passaretti B, et al. Pericardial Stentless Valve for Aortic Valve Replacement: Long-Term Results. Ann Thorac Surg. 2016;102(6):1956–65. doi:.https://doi.org/10.1016/j.athoracsur.2016.05.080
  10. Sponga S, Barbera MD, Pavoni D, Lechiancole A, Mazzaro E, Valente M, et al. Ten-year results of the Freedom Solo stentless heart valve: excellent haemodynamics but progressive valve dysfunction in the long term. Interact Cardiovasc Thorac Surg. 2017;24(5):663–9. doi:.https://doi.org/10.1093/icvts/ivw391

Most read articles by the same author(s)